The latest price target for Humana (NYSE:HUM) was reported by Jefferies on December 5, 2025. The analyst firm set a price target for $313.00 expecting HUM to rise to within 12 months (a possible 16.18% upside). 41 analyst firms have reported ratings in the last year.

The latest analyst rating for Humana (NYSE:HUM) was provided by Jefferies, and Humana upgraded their buy rating.

The last upgrade for Humana Inc happened on December 5, 2025 when Jefferies raised their price target to $313. Jefferies previously had a hold for Humana Inc.

The last downgrade for Humana Inc happened on October 7, 2024 when TD Cowen changed their price target from $402 to $261 for Humana Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humana was filed on December 5, 2025 so you should expect the next rating to be made available sometime around December 5, 2026.

While ratings are subjective and will change, the latest Humana (HUM) rating was a upgraded with a price target of $253.00 to $313.00. The current price Humana (HUM) is trading at is $269.40, which is within the analyst’s predicted range.